Close association between activated platelets and neutrophils in the active phase of ulcerative colitis in humans

Inflammatory Bowel Diseases

Volumn 12, Issue 8, 2006, Pages 727-735

  Kayo, Soichiro ^a   Ikura, Yoshihiro ^a   Suekane, Takehisa ^a   Shirai, Nobuyuki ^a   Sugama, Yoshimi ^a   Ohsawa, Masahiko ^a   Adachi, Kenji ^b   Watanabe, Kenji ^a   Nakamura, Shiro ^a   Fujiwara, Yasuhiro ^a   Oshitani, Nobuhide ^a   Higuchi, Kazuhide ^a   Maeda, Kiyoshi ^a   Hirakawa, Kosei ^a   Arakawa, Tetsuo ^a   Ueda, Makiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka City Sumiyoshi Hospital   (Japan)

Author keywords

Flow cytometry; Immunohistochemistry; Neutrophil; Platelet; Ulcerative colitis

Indexed keywords

CD3 ANTIGEN; FIBRINOGEN RECEPTOR; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; PADGEM PROTEIN; PROTEIN CD66B; STEROID; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CELL COMMUNICATION; CELL INFILTRATION; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MORPHOMETRICS; NEUTROPHIL CHEMOTAXIS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; COLON; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; P-SELECTIN; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 33747386471     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/00054725-200608000-00009     Document Type: Article

References (45)

1. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365-376.
2. Robinson CE, Kottapalli V, D'Astice M, et al. Regulation of neutrophils in ulcerative colitis by colonic factors: a possible mechanism of neutrophil activation and tissue damage. J Lab Clin Med. 1997;130:590-602.
3. Fenoglio-Preiser CM, Noffsinger AE, Stemmermann GN, et al. Ulcerative colitis. In: Gastrointestinal Pathology: An Atlas and Text, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1999:659-678.
4. Sawada K, Ohnishi K, Fukui S, et al. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol. 1995;30:322-329.
5. Kashiwagi N, Sugimura K, Koiwai H, et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci. 2002;47:1334-1341.
6. Spisani S, Giuliani AL, Cavalletti T, et al. Modulation of neutrophil functions by activated platelet release factors. Inflammation. 1992;16:147-158.
7. von Asmuth EJ, Buurman WA. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha-induced H2O2 release by adherent neutrophil leukocytes. J Immunol. 1995;154:1383-1390.
8. Ezekowitz RA, Sim RB, MacPherson GG, et al. Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement. J Clin Invest. 1985;76:2368-2376.
9. Page CP. Platelets as inflammatory cells. Immunopharmacology. 1989;17:51-59.
10. Bazzoni G, Dejana E, Del Maschio A. Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica. 1991;76:491-499.
11. Aukrust P, Waehre T, Damas JK, et al. Inflammatory role of platelets in acute coronary syndromes. Heart. 2001;86:605-606.
12. Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation. 2001;103:1718-1720.
13. Naruko T, Ueda M, Haze K, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106:2894-2900.
14. Kayo S, Ohsawa M, Ehara S, et al. Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction. Am Heart J. 2004;148:818-825.
15. Ikuta T, Naruko T, Ikura Y, et al. Immunolocalization of platelet glycoprotein IIb/IIIa and P-selectin, and neutrophil-platelet interaction in human coronary unstable plaques. Int J Mol Med. 2005;15:573-577.
16. Danese S, de la Motte CD, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol. 2004;99:938-945.
17. Collins CE, Rampton DS, Rogers J, et al. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1997;9:1213-1217.
18. Suzuki K, Sugimura K, Hasegawa K, et al. Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand J Gastroenterol. 2001;36:1301-1306.
19. Talstad I, Rootwelt K, Gjone E. Thrombocytosis in ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 1973;8:135-138.
20. Collins CE, Cahill MR, Newland AC, et al. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology. 1994;106:840-845.
21. Solem CA, Loftus EV, Tremaine WJ, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99:97-101.
22. Dhillon AP, Anthony A, Sim R, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology. 1992;21:127-133.
23. More L, Sim R, Hudson M, et al. Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease. J Clin Pathol. 1993;46:703-708.
24. Schurmann GM, Bishop AE, Facer P, et al. Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut. 1995;36:411-418.
25. Danese S, de la Motte C, Sturm A, et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology. 2003;124:1249-1264.
26. Stenberg PE, McEver RP, Shuman MA, et al. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 1985;101:880-886.
27. Berman CL, Yeo EL, Wencel-Drake JD, et al. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest. 1986;78:130-137.
28. Rinder HM, Snyder EL, Bonan JL, et al. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release. Transfusion. 1993;33:25-29.
29. Hagberg IA, Roald HE, Lyberg T. Platelet activation in flowing blood passing growing arterial thrombi. Arterioscler Thromb Vasc Biol. 1997;17:1331-1336.
30. Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987;92:1894-1898.
31. Schmitz G, Rothe G, Ruf A, et al. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost. 1998;79:885-896.
32. Zar JH. Two-sample hypotheses. In: Biostatistical Analysis, 2nd ed. Englewood Cliffs, NJ: Prentice-Hall, 1984:122-149.
33. Nagata K, Tsuji T, Todoroki N, et al. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol. 1993;151:3267-3273.
34. Zhao L, Bath PM, May J, et al. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist. Platelets. 2003;14:473-480.
35. Bengtsson T, Fryden A, Zalavary S, et al. Platelets enhance neutrophil locomotion: evidence for a role of P-selectin. Scand J Clin Lab Invest. 1999;59:439-449.
36. Cooper D, Chitman KD, Williams MC, et al. Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol. 2003;284:G1027-G1033.
37. Bonomini M, Stuard S, Carreno MP, et al. Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin. Nephron. 1997;75:402-411.
38. Glaser CB, Morser J, Clarke JH, et al. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Invest. 1992;90:2565-2573.
39. LaRosa CA, Rohrer MJ, Benoit SE, et al. Human neutrophil cathepsin G is a potent platelet activator. J Vasc Surg. 1994;19:306-318.
40. Vowinkel T, Mori M, Krieglstein CF, et al. Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest. 2004;114:260-269.
41. Mori M, Salter JW, Vowinkel T, et al. Molecular determinants of the prothrombogenic phenotype assumed by inflamed colonic venules. Am J Physiol Gastrointest Liver Physiol. 2005;288:G920-G926.
42. Cason J, Ainley CC, Wolstencroft RA, et al. Polymorphonuclear leucocytes in Crohn's disease and ulcerative proctocolitis: association between enhanced adherence to nylon fibre and disease variables. J Clin Pathol. 1988;41:241-246.
43. Matsuo T, Ikura Y, Ohsawa M, et al. Mast cell chymase expression in Helicobacter pylori-associated gastritis. Histopathology. 2003;43:538-549.
44. Kumar V, Abbas AK, Fausto N. Acute and chronic inflammation. In: Pathologic Basis of Disease, 7th ed. Philadelphia: Elsevier, 2004:47-86.
45. John TJ. Leukocytosis during steroid therapy. Am J Dis Child. 1966;111:68-70.